When was Phoenix Biosystem founded?

Phoenix Biosystem was founded in 2001 and raised its 1st funding round 8 years after it was founded.

Where is Phoenix Biosystem located?

Phoenix Biosystem is headquartered in Serpentine, Australia.

How many employees does Phoenix Biosystem have?

As of Sep 30, 2026, the latest employee count at Phoenix Biosystem is 3.

Is Phoenix Biosystem a funded company?

Phoenix Biosystem is a funded company, having raised an undisclosed amount across 9 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Sep 22, 2009.

When was the latest funding round of Phoenix Biosystem?

Phoenix Biosystem's latest funding was a $***** Grant (prize money) round on May 07, 2020, with participation from 1 investor.

Where does Phoenix Biosystem rank among its competitors?

Phoenix Biosystem ranks 12th amongst 17 active competitors, of which 6 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Haga Bio Science, which secured $2.3M in Jun, 2026.

Who are the top competitors of Phoenix Biosystem?

Phoenix Biosystem's top competitors include Araceli Biosciences, ACD and Lodestone Biomedical. Among them, Haga Bio Science secured the most recent funding round in June, 2026.

Phoenix Biosystem - 2026 Company Profile, Funding & Competitors

Company Details

Developer of biomarker panels and assays for disease assessment and detection. It focuses on developing biomarker panels for sleep disorders assessment at the point-of-care. Additionally, it develops novel alcohol biomarkers in whole blood. The company also creates biomarkers for staging Alzheimer's disease. Furthermore, it develops point-of-care assays for diabetes auto-antibody detection. It also researches protective antibody responses for an adjuvanted HIV vaccine.

Website: phoenixbiosystem.com
Email ID: *****@phoenixbiosystem.com
Phone Number: +1 **********

Key Metrics

Founded Year

2001

Location

Serpentine, Australia

Stage

Funding Raised

Latest Funding Round

Grant (prize money), May 07, 2020, $*****

Investors

National Science Foundation & 1 more

Ranked

12^th among 17 active competitors

Employee Count

3 as on Sep 30, 2026

Similar Companies

Araceli Biosciences & 18 more

View Phoenix Biosystem's full profile

Phoenix Biosystem has raised funding over 9 rounds. Its first funding round was on Sep 22, 2009. Its latest funding round was a Grant (prize money) round on May 07, 2020 for $*****. 1 investor participated in its latest round. Phoenix Biosystem has 2 institutional investors.

Here is the list of recent funding rounds of Phoenix Biosystem:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 07, 2020	3117051	Grant (prize money)	1517137	2636636	9542980	3026355
Aug 15, 2016	3359657	Grant (prize money)	3469534	8305824	5096285	HHS
Apr 12, 2016	2562537	Grant (prize money)	4210476	4823030	2888198	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Phoenix Biosystem's funding rounds and investors

Phoenix Biosystem's employee count trend

Phoenix Biosystem has 3 employees as of Sep 26. Here is Phoenix Biosystem's employee count trend over the years:

Employee count trend for Phoenix Biosystem

Uncover Phoenix Biosystem's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Phoenix Biosystem include Araceli Biosciences, ACD and Lodestone Biomedical. Here is the list of Top 10 competitors of Phoenix Biosystem, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Araceli Biosciences 2020, United States, Seed	Developer of scientific tools for tissue and cell-based biomarker discovery & drug development	$25.7M	-	53/100
2nd	ACD 2006, Newark (United States), Acquired	Developer of a transnational research platform for biomarker analysis	$39.4M	Summit Partners, Morningside & 5 others	52/100
3rd	Lodestone Biomedical 2015, Hanover (United States), Seed	Provider of magnetic nanoparticle platform technology for in vivo biomarker monitoring in immuno-oncology	$1.18M	MassChallenge, Dartmouth Regional Technology Center ... Read more	41/100
4th	BioAmp Diagnostics 2017, Berkeley (United States), Seed	Developers of diagnostic tests that help to treat patient with a specific antibiotic	-	Illumina, CITRIS Foundry & 8 others	35/100
5th	BioImage 1999, Copenhagen (Denmark), Acqui-Hired	Developer of bioassays for biopharmaceutical companies and research institutions	$30.5M	Abingworth, Novo Holdings & 3 others	32/100
6th	HAWK Biosystems 2015, Derio (Spain), Seed	Developer of clinical assays for quantifying novel biomarkers	-	EIC Fund, Europa	30/100
7th	Haga Bio Science Solna (Sweden), Seed	Developer of spatial RNA detection assays for clinical biomarker validation	$2.3M	Almi Invest, Life Science Invest	27/100
8th	Fyr Missoula (United States), Unfunded	Provider of extracellular vesicle omics platform for precision medicine advancement	-	-	25/100
9th	ACS Biomarker 2007, Maastricht (Netherlands), Series A	ACS Biomarker is a Dutch biotechnology company focusing on the discovery, validation and commercialization of novel biomarkers for cardiac disease.	-	Brightlands Venture Partners, Life Sciences Fund Amsterdam ... & 3 others	24/100
10th	Cellkey 2019, Cheongju (South Korea), Unfunded	Provider of AI-driven multiomics data analysis and biomarker discovery solutions	-	-	24/100
12th	Phoenix Biosystem 2001, Serpentine (Australia), Funding Raised	Developer of biomarker panels and assays for disease assessment and detection	-	National Science Foundation, HHS	24/100